Skip to main content
Clinical Trials/ACTRN12608000424303
ACTRN12608000424303RecruitingPhase 3

A double blind placebo-controlled randomized clinical trial of the use of oral azithromycin in Aboriginal children between 6 months and 30 months of age presenting with asymptomatic acute otitis media without perforation

Menzies School of Health Research0 sites300 target enrollmentStarted: August 25, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
6 Months to 30 Months (—)
Sex
All

Inclusion Criteria

  • 1. Informed consent obtained and signed
  • 2. All Aboriginal children aged 6 months and 30 months of age on the date of randomisation who are resident in participating communities will be eligible to be screened for asymptomatic acute otitis media without perforation.
  • 3. The following inclusion criteria for the randomized controlled trial (RCT) will be applied to children diagnosed with asymptomatic acute otitis media:
  • a.) A bulging tympanic membrane.
  • b.) No associated symptoms at the time of diagnosis (including ear pain or fever).
  • 4. Children who have a diagnosis of asymptomatic acute otitis media who are able to attend the clinic for follow up visits at day 7, day 14 and day 28.

Exclusion Criteria

  • 1. Acute otitis media with ear pain or fever
  • 2. Acute otitis media with recent onset of perforation and discharge (within 7 days)
  • 3. Chronic suppurative otitis media
  • 4. Previously been randomised into this study
  • 5. Have received antibiotics in the previous 7 days (not including topical antibiotics)
  • 6. A more severe illness requiring antibiotics
  • 7. Azithromycin allergy
  • 8. Immunodeficiency

Investigators

Similar Trials

Antibtiotics for Asymptomatic Acute Otitis... | Clinical Trial